National

Odds-defying Prostate Cancer Drug Developed In B.C. Hits Clinical Trials

Darpan News Desk, 02 Dec, 2015 02:02 PM

VANCOUVER — A made-in-British Columbia treatment is offering fresh hope to men battling prostate cancer.

Researchers at the B.C. Cancer Agency and the University of British Columbia have been approved to leave the lab with their odds-defying breakthrough drug and begin clinical trials.

B.C. Cancer Agency scientist Dr. Marianne Sadar says the statistical chances of reaching this milestone of are one in 1,000.

The new drug — dubbed EPI-506 — targets the end of a protein on prostate cancer cells to make them more vulnerable to hormones like testosterone.

While the effectiveness of earlier trial drugs that targeted the protein's front quickly waned, lab research indicates this new treatment successfully slows tumour growth past the early stages of treatment.

Phase I clinical trials begin today at sites across North America for the drug, which received $2.6 million from the B.C. Cancer Foundation over its 17-year development.

Prev Next

MORE National ARTICLES

Don't Fear Us, Even The Single Men, Syrian Refugees Tell Canadians

AMMAN, Jordan — Khaled Dos says he understands why Canada is focusing on families as it chooses thousands of potential new citizens from among the millions of Syrian refugees desperate for a fresh start.

Don't Fear Us, Even The Single Men, Syrian Refugees Tell Canadians

Breast Milk Site To Open In Winnipeg; Donations To Help Sick Babies

WINNIPEG — The Winnipeg Regional Health Authority is opening a site where registered donations of breast milk will be accepted.

Breast Milk Site To Open In Winnipeg; Donations To Help Sick Babies

B.C. Union Workers Say They Want Legalized Pot To Be Sold In Their Stores

BURNABY, B.C. — The unions representing British Columbia liquor retail workers want legalized marijuana to be sold in their stores.

B.C. Union Workers Say They Want Legalized Pot To Be Sold In Their Stores

Bank Of Canada Keeps Benchmark Rate At 0.5% With Economy Unfolding As Expected

OTTAWA — The Bank of Canada left its trend-setting interest rate unchanged Wednesday, saying the economy is adjusting as expected to the bite of low commodity prices and weaker-than-anticipated U.S. demand.